Can a quick zap after liver surgery keep cancer away?
NCT ID NCT05492136
First seen Jun 26, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This study is testing whether applying a radiofrequency device to the cut surface of the liver after tumor removal can reduce the chance of cancer returning at that spot. About 720 adults with liver cancer (either colorectal metastases or hepatocellular carcinoma) will be randomly assigned to receive either standard surgery or surgery plus this extra coagulation step. The main goal is to see if local recurrence rates are lower in the group that gets the extra treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- radiofrequency coagulation procedure
- What this could lead to
- If successful, this could provide a simple, low-cost way to lower the chance of liver cancer coming back after surgery.
- What could go wrong
- This is an early-stage trial testing a technique already used in practice, so the benefit may be small or none. There is also a risk of liver damage from the extra coagulation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER, TREATMENT-RELATED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital del Mar Research Institute
RECRUITINGBarcelona, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Could a vaccine help fight Hard-to-Treat cancers?
- Could a tailored diet before surgery boost liver cancer recovery?
- Can a new PET tracer light up hidden cancers?
- A new test could reveal how radiation affects the liver
- Can an immunotherapy drug keep liver cancer at bay after surgery?